These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17340549)

  • 21. Effects of a cognition-emotion focused program to increase public participation in Papanicolaou smear screening.
    Park S; Chang S; Chung C
    Public Health Nurs; 2005; 22(4):289-98. PubMed ID: 16150010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
    Sepúlveda C; Prado R
    Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Perceived barriers to taking a Pap smear: predictors in immigrant women].
    Wu SJ; Tsai SH; Tseng HF; Huang YY; Wang YH; Lin SY
    Hu Li Za Zhi; 2010 Oct; 57(5):36-46. PubMed ID: 20878609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pap screening in a U.S. health plan.
    Insinga RP; Glass AG; Rush BB
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):355-60. PubMed ID: 15006908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge, attitude and practice of cervical cancer screening (pap smear) among female nurses in Nnewi, South Eastern Nigeria.
    Udigwe GO
    Niger J Clin Pract; 2006 Jun; 9(1):40-3. PubMed ID: 16986288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Have a Pap smear!'--doctors, their clients, and opportunistic cervical cancer screening.
    Chingang LC; Bischof U; Andall-Brereton G; Razum O
    Int J STD AIDS; 2005 Mar; 16(3):233-6. PubMed ID: 15829024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-reports of Pap smear screening in women with physical disabilities.
    Lin JD; Chen SF; Lin LP; Sung CL
    Res Dev Disabil; 2011; 32(2):456-61. PubMed ID: 21273042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan.
    Koong SL; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S44-7. PubMed ID: 17227642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Knowledge and use of Pap-smear among HIV-positive women].
    Pavia C; Navarra A; Pisani G; Piselli P; Koehler B; Angeletti C; Ippolito G; Serraino D
    Minerva Ginecol; 2006 Jun; 58(3):233-8. PubMed ID: 16783295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social inequality in Pap smear coverage: identifying under-users of cervical cancer screening in Argentina.
    Arrossi S; Ramos S; Paolino M; Sankaranarayanan R
    Reprod Health Matters; 2008 Nov; 16(32):50-8. PubMed ID: 19027622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pap smear screening and invasive cervical cancer.
    Brown RK; Barker WH
    J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].
    Mignotte H; Perol D; Fontanière B; Nachury LP; Blanc-Jouvand A; Fouillat V; Chauvin F; Lasset C
    Bull Cancer; 1999 Jun; 86(6):573-9. PubMed ID: 10417430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
    Papa D; Moore Simas TA; Reynolds M; Melnitsky H
    J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of organized screening on incidence and mortality of cervical cancer in Denmark.
    Lynge E; Madsen M; Engholm G
    Cancer Res; 1989 Apr; 49(8):2157-60. PubMed ID: 2702657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
    Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
    BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.